Studies on the biosynthesis of the .ALPHA.-glucosidase inhibitor acarbose. Valienamine, a m-C7N unit not derived from the shikimate pathway.
- 1 January 1987
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 40 (6), 855-861
- https://doi.org/10.7164/antibiotics.40.855
Abstract
Feeding experiments with Actinoplanes sp. Sn223/29 showed that 3-amino-5-hydroxy/[7-13C]benzoic acid is not incorporated into acarbose (I). The valienamine moiety of I is thus not derived in the same way, from the shikimate pathway, as the m-CN units in the ansamycin, mitomycin and ansamitocin antibiotics. Feeding experiments with [U-13C]-glycerol followed by analysis of I by multiple quantum NMR spectroscopy support this conclusion and point to formation of the valienamine moiety by cyclization of a heptulose phosphate which arises from a triose phosphate via successive transfer of two 2-carbon fragments by transketolase, as proposed by PAPE and co-workers.This publication has 3 references indexed in Scilit:
- Untersuchungen zur struktur des α-d-glucosidaseinhibitors acarboseCarbohydrate Research, 1984
- A genetic approach to the biosynthesis of the Rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit.The Journal of Antibiotics, 1981
- Synthesis of unlabelled and carboxyl-labelled 3-Amino-5-hydroxybenzoic acidAustralian Journal of Chemistry, 1981